.
  • NIFTY 24,741.00 +6.70 (+0.03%)
  • SENSEX 80,710.76 -7.25 (-0.01%)
BSE
NSE

Friday, September 05, 2025 , BSE Sensex : 80,710.76 80,710.76(-0.01%) , Adani Ports : 1,321.90 1,321.90(-0.49%) , Asian Paints : 2,578.90 2,578.90(0.39%) , Axis Bank : 1,056.20 1,056.20(0.57%) , Bajaj Finance : 937.65 937.65(0.30%) , Bajaj Finserv : 2,014.10 2,014.10(0.59%) , Bharat Electron : 370.95 370.95(-0.44%) , Bharti Airtel : 1,896.40 1,896.40(0.86%) , Eternal Ltd : 329.20 329.20(0.83%) , HCL Technologies : 1,419.55 1,419.55(-1.64%) , HDFC Bank : 962.90 962.90(0.18%) , Hind. Unilever : 2,633.20 2,633.20(-1.28%) , ICICI Bank : 1,402.70 1,402.70(-0.21%) , Infosys : 1,444.35 1,444.35(-1.29%) , ITC : 407.50 407.50(-2.01%) , Kotak Mah. Bank : 1,944.00 1,944.00(-0.30%) , Larsen & Toubro : 3,552.75 3,552.75(-1.11%) , M & M : 3,561.55 3,561.55(2.34%) , Maruti Suzuki : 14,904.50 14,904.50(1.70%) , NTPC : 328.70 328.70(-0.45%) , Power Grid Corpn : 285.40 285.40(1.21%) , Reliance Industr : 1,374.30 1,374.30(1.11%) , SBI : 806.95 806.95(-0.30%) , Sun Pharma.Inds. : 1,594.70 1,594.70(0.78%) , Tata Motors : 691.85 691.85(0.63%) , Tata Steel : 167.65 167.65(0.54%) , TCS : 3,048.45 3,048.45(-1.53%) , Tech Mahindra : 1,477.65 1,477.65(-1.55%) , Titan Company : 3,665.25 3,665.25(-0.57%) , Trent : 5,523.80 5,523.80(-0.02%) , UltraTech Cem. : 12,596.90 12,596.90(-0.46%) ,

Nifty 50 : 24,741.00 6.70(0.03%) , Adani Enterp. : 2,281.40 2.60(0.11%) , Adani Ports : 1,321.80 -6.40(-0.48%) , Apollo Hospitals : 7,804.50 -95.50(-1.21%) , Asian Paints : 2,579.90 11.30(0.44%) , Axis Bank : 1,055.90 5.50(0.52%) , Bajaj Auto : 9,084.50 13.50(0.15%) , Bajaj Finance : 937.60 2.85(0.30%) , Bajaj Finserv : 2,014.40 12.20(0.61%) , Bharat Electron : 370.80 -1.70(-0.46%) , Bharti Airtel : 1,895.30 14.90(0.79%) , Cipla : 1,553.40 -24.40(-1.55%) , Coal India : 392.65 1.20(0.31%) , Dr Reddy's Labs : 1,268.10 15.10(1.21%) , Eicher Motors : 6,580.50 155.50(2.42%) , Eternal Ltd : 329.15 2.90(0.89%) , Grasim Inds : 2,804.00 -5.80(-0.21%) , HCL Technologies : 1,419.00 -24.30(-1.68%) , HDFC Bank : 963.40 2.15(0.22%) , HDFC Life Insur. : 759.55 5.30(0.70%) , Hero Motocorp : 5,363.00 12.00(0.22%) , Hind. Unilever : 2,633.40 -33.20(-1.25%) , Hindalco Inds. : 743.80 4.75(0.64%) , ICICI Bank : 1,402.80 -2.70(-0.19%) , IndusInd Bank : 757.05 2.20(0.29%) , Infosys : 1,444.60 -18.40(-1.26%) , ITC : 407.35 -8.55(-2.06%) , Jio Financial : 309.40 -0.05(-0.02%) , JSW Steel : 1,073.10 0.70(0.07%) , Kotak Mah. Bank : 1,945.50 -4.20(-0.22%) , Larsen & Toubro : 3,553.60 -39.00(-1.09%) , M & M : 3,561.30 79.80(2.29%) , Maruti Suzuki : 14,895.00 233.00(1.59%) , Nestle India : 1,208.50 -4.10(-0.34%) , NTPC : 328.70 -1.35(-0.41%) , O N G C : 234.13 -1.59(-0.67%) , Power Grid Corpn : 285.35 3.55(1.26%) , Reliance Industr : 1,375.00 15.70(1.16%) , SBI : 806.60 -2.80(-0.35%) , SBI Life Insuran : 1,805.30 14.20(0.79%) , Shriram Finance : 592.50 6.70(1.14%) , Sun Pharma.Inds. : 1,593.60 11.30(0.71%) , Tata Consumer : 1,072.40 1.30(0.12%) , Tata Motors : 691.70 4.20(0.61%) , Tata Steel : 167.68 0.87(0.52%) , TCS : 3,048.30 -47.40(-1.53%) , Tech Mahindra : 1,477.90 -22.50(-1.50%) , Titan Company : 3,665.30 -25.80(-0.70%) , Trent : 5,528.50 -0.50(-0.01%) , UltraTech Cem. : 12,601.00 -50.00(-0.40%) , Wipro : 243.67 -1.30(-0.53%) , Friday, September 05, 2025

Home >> Markets >> Equities >> News - News Details
Corporate News
04-Sep-2025     18:36
Zydus enters into licensing and supply agreement with Synthon BV

Zydus Lifesciences today announced that its wholly owned subsidiary, Zydus Lifesciences Global FZE, has entered into an exclusive licensing and supply agreement with Synthon BV of the Netherlands for Ozanimod Capsules (a generic version of ZEPOSIA') for the U.S. market. Synthon has a pending abbreviated new drug application in the United States, seeking approval for Ozanimod Capsules indicated for relapsing forms of multiple sclerosis.

Under the terms of this agreement, Synthon will be responsible for obtaining final regulatory approval for its Ozanimod Capsules product, and thereafter, for the manufacture and supply of the product. Zydus will be responsible for the commercialization of the product in the USA. As one of the first filers, Synthon has received tentative approval within 30 months from U.S. Food and Drug Administration (FDA), making the product eligible for a shared 180-day exclusivity upon market entry.

ZEPOSIA' (Ozanimod) is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. It is also approved for moderately to severely active ulcerative colitis (UC) in adults. ZEPOSIA' is a trademark of Receptos, LLC, a Bristol Myers Squibb company.

Powered by Capital Market - Live News